Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Liquid biopsy captures key NASH pathology hallmarks
Key clinical point: Large-scale protein scanning offers the potential for noninvasive screening for nonalcoholic steatohepatitis (NASH).
Major finding: Protein scanning identified four key components of NASH with 83%-95% accuracy.
Study details: Retrospective study of about 5,000 proteins in serum from 2,852 patients with NASH.
Disclosures: The study was sponsored by SomaLogic. The authors are employees of the company.
Citation:
Ostroff R et al. The Liver Disease Meeting Digital Experience, Abstract LP11.